122P Abemaciclib in HR+/HER2- metastatic breast cancer: A real-world experience
Bottosso, M., Giarratano, T., Barbieri, C., Menichetti, A., Cumerlato, E., Miglietta, F., Genovesi, E., Amato, O., Dieci, M.V., Griguolo, G., Guarneri, V.
Published in Annals of oncology (01.05.2021)
Published in Annals of oncology (01.05.2021)
Get full text
Journal Article
99P Association of gut microbiome diversity and composition with pathological complete response (pCR) after neoadjuvant chemotherapy in triple negative breast cancer
Vernaci, G., Cumerlato, E., Griguolo, G., Massa, D., Menichetti, A., Miglietta, F., Tasca, G., Savarino, E., Conte, P.F., Guarneri, V., Dieci, M.V.
Published in Annals of oncology (01.05.2020)
Published in Annals of oncology (01.05.2020)
Get full text
Journal Article
Abstract P4-08-04: PD-L1 expression and prognosis in triple negative breast cancer (TNBC): An analysis of 265 patients (pts) treated with standard therapy for stage I-III disease
Dieci, MV, Orvieto, E, Tsvetkova, V, Griguolo, G, Miglietta, F, Bonaguro, S, Tasca, G, Giorgi, CA, Cumerlato, E, Guarneri, V, Conte, P
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article